{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T18:42:05Z","timestamp":1740163325312,"version":"3.37.3"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100018925","name":"Health Commission of Henan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016305","name":"First Affiliated Hospital of Zhengzhou University","doi-asserted-by":"publisher","award":["KY-2021-00911"],"award-info":[{"award-number":["KY-2021-00911"]}],"id":[{"id":"10.13039\/501100016305","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017700","name":"Henan Provincial Science and Technology Research Project","doi-asserted-by":"publisher","award":["SB201901003"],"award-info":[{"award-number":["SB201901003"]}],"id":[{"id":"10.13039\/501100017700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hepatobiliary & Pancreatic Diseases International"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.hbpd.2023.03.005","type":"journal-article","created":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T00:22:20Z","timestamp":1679358140000},"page":"370-375","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development of a prognostic scoring system for hepatic vena cava Budd-Chiari syndrome with hepatocellular carcinoma"],"prefix":"10.1016","volume":"23","author":[{"given":"Sheng-Yan","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu-Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhao-Chen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su-Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Wei","family":"Dang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hbpd.2023.03.005_bib0001","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/apt.15149","article-title":"Review article: a multidisciplinary approach to the diagnosis and management of Budd-Chiari syndrome","volume":"49","author":"Khan","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.hbpd.2023.03.005_bib0002","doi-asserted-by":"crossref","first-page":"691","DOI":"10.4254\/wjh.v8.i16.691","article-title":"Redefining Budd-Chiari syndrome: a systematic review","volume":"8","author":"Shin","year":"2016","journal-title":"World J Hepatol"},{"key":"10.1016\/j.hbpd.2023.03.005_bib0003","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1111\/apt.13815","article-title":"Review article: the aetiology of primary Budd-Chiari syndrome - differences between the West and China","volume":"44","author":"Qi","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.hbpd.2023.03.005_bib0004","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s12072-021-10189-4","article-title":"Budd-Chiari syndrome: consensus guidance of the Asian Pacific Association for the study of the liver (APASL)","volume":"15","author":"Shukla","year":"2021","journal-title":"Hepatol Int"},{"key":"10.1016\/j.hbpd.2023.03.005_bib0005","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.cld.2020.04.012","article-title":"Budd-Chiari syndrome: an uncommon cause of chronic liver disease that cannot be missed","volume":"24","author":"Haque","year":"2020","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.hbpd.2023.03.005_bib0006","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.hbpd.2021.12.004","article-title":"Management of hepatocellular carcinoma patients with portal vein tumor thrombosis: a narrative review","volume":"21","author":"Tao","year":"2022","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.hbpd.2023.03.005_bib0007","doi-asserted-by":"crossref","first-page":"874","DOI":"10.4254\/wjh.v7.i6.874","article-title":"Liver cirrhosis in hepatic vena cava syndrome (or membranous obstruction of inferior vena cava)","volume":"7","author":"Shrestha","year":"2015","journal-title":"World J Hepatol"},{"key":"10.1016\/j.hbpd.2023.03.005_bib0008","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1148\/radiol.09090738","article-title":"Hepatocellular carcinoma associated with membranous obstruction of the inferior vena cava: incidence, characteristics, and risk factors and clinical efficacy of TACE","volume":"254","author":"Gwon","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.hbpd.2023.03.005_bib0009","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/1471-230X-13-105","article-title":"Hepatocellular carcinoma associated with Budd-Chiari syndrome: imaging features and transcatheter arterial chemoembolization","volume":"13","author":"Liu","year":"2013","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.hbpd.2023.03.005_bib0010","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.3760\/cma.j.issn.0366-6999.20130898","article-title":"Clinical and pathological features and surgical treatment of Budd-Chiari syndrome-associated hepatocellular carcinoma","volume":"126","author":"Wang","year":"2013","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.hbpd.2023.03.005_bib0011","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/sim.1742","article-title":"Presentation of multivariate data for clinical use: the Framingham Study risk score functions","volume":"23","author":"Sullivan","year":"2004","journal-title":"Stat Med"},{"key":"10.1016\/j.hbpd.2023.03.005_bib0012","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/hepr.12869","article-title":"Hepatic vena cava syndrome: new concept of pathogenesis","volume":"47","author":"Shrestha","year":"2017","journal-title":"Hepatol Res"},{"key":"10.1016\/j.hbpd.2023.03.005_bib0013","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00042737-200403000-00012","article-title":"Characteristic clinical features of hepatocellular carcinoma associated with Budd-Chiari syndrome: evidence of different carcinogenic process from hepatitis B virus-associated hepatocellular carcinoma","volume":"16","author":"Shin","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2023.03.005_bib0014","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1148\/radiol.12120856","article-title":"Percutaneous recanalization for Budd-Chiari syndrome: an 11-year retrospective study on patency and survival in 177 Chinese patients from a single center","volume":"266","author":"Han","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.hbpd.2023.03.005_bib0015","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/liv.15115","article-title":"Molecular mechanism of albumin in suppressing invasion and metastasis of hepatocellular carcinoma","volume":"42","author":"Fu","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.hbpd.2023.03.005_bib0016","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.3390\/ijms15035163","article-title":"Albumin suppresses human hepatocellular carcinoma proliferation and the cell cycle","volume":"15","author":"Nojiri","year":"2014","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.hbpd.2023.03.005_bib0017","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","article-title":"Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade","volume":"33","author":"Johnson","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hbpd.2023.03.005_bib0018","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1093\/annonc\/mdt247","article-title":"A simple prognostic scoring system for patients receiving transarterial embolisation for hepatocellular cancer","volume":"24","author":"Kadalayil","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.hbpd.2023.03.005_bib0019","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2147\/CMAR.S22073","article-title":"Factors influencing distant recurrence of hepatocellular carcinoma following combined radiofrequency ablation and transarterial chemoembolization therapy in patients with hepatitis C","volume":"3","author":"Nojiri","year":"2011","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.hbpd.2023.03.005_bib0020","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ejso.2021.09.012","article-title":"Systematic review and meta-analysis of validated prognostic models for resected hepatocellular carcinoma patients","volume":"48","author":"Beumer","year":"2022","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.hbpd.2023.03.005_bib0021","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1007\/s00268-018-4658-y","article-title":"The predictors of microscopic vessel invasion differ between primary hepatocellular carcinoma and hepatocellular carcinoma with a treatment history","volume":"42","author":"Okamura","year":"2018","journal-title":"World J Surg"},{"key":"10.1016\/j.hbpd.2023.03.005_bib0022","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.2147\/CMAR.S177663","article-title":"Importance of tumor size at diagnosis as a prognostic factor for hepatocellular carcinoma survival: a population-based study","volume":"10","author":"Wu","year":"2018","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.hbpd.2023.03.005_bib0023","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/gut.2007.139477","article-title":"Hepatocellular carcinoma in Budd-Chiari syndrome: characteristics and risk factors","volume":"57","author":"Moucari","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.hbpd.2023.03.005_bib0024","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1097\/MEG.0b013e32835eb8d4","article-title":"Prevalence and risk factors of hepatocellular carcinoma in Budd-Chiari syndrome: a systematic review","volume":"25","author":"Ren","year":"2013","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2023.03.005_bib0025","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.3748\/wjg.v18.i16.1946","article-title":"Hepatocellular carcinoma in Budd-Chiari syndrome: a single center experience with long-term follow-up in South Korea","volume":"18","author":"Park","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.hbpd.2023.03.005_bib0026","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/apt.13173","article-title":"Incidence and risk factors of hepatocellular carcinoma in patients with hepatic venous outflow tract obstruction","volume":"41","author":"Paul","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.hbpd.2023.03.005_bib0027","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S2468-1253(19)30177-3","article-title":"Angioplasty with versus without routine stent placement for Budd-Chiari syndrome: a randomised controlled trial","volume":"4","author":"Wang","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2023.03.005_bib0028","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.jhep.2021.11.013","article-title":"The importance of liver functional reserve in the non-surgical treatment of hepatocellular carcinoma","volume":"76","author":"D'Avola","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2023.03.005_bib0029","doi-asserted-by":"crossref","first-page":"959","DOI":"10.2169\/internalmedicine.8020-21","article-title":"The albumin-bilirubin score detects changes in the liver function during treatment for Budd-Chiari syndrome: a retrospective observational study","volume":"61","author":"Kageyama","year":"2022","journal-title":"Intern Med"},{"key":"10.1016\/j.hbpd.2023.03.005_bib0030","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.acra.2018.05.003","article-title":"Clinical efficacy of spectral computed tomography for evaluating liver function in patients with Budd-Chiari syndrome","volume":"26","author":"Su","year":"2019","journal-title":"Acad Radiol"},{"key":"10.1016\/j.hbpd.2023.03.005_bib0031","doi-asserted-by":"crossref","first-page":"S179","DOI":"10.1016\/j.acra.2021.02.016","article-title":"Evaluating the short-term clinical efficacy of magnetic resonance elastography in patients with Budd-Chiari syndrome","volume":"28","author":"Xu","year":"2021","journal-title":"Acad Radiol"},{"key":"10.1016\/j.hbpd.2023.03.005_bib0032","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/hep.32256","article-title":"Sphingosine-1-phosphate promotes tumor development and liver fibrosis in mouse model of congestive hepatopathy","volume":"76","author":"Kawai","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2023.03.005_bib0033","first-page":"384","article-title":"Liver pathology changes in Budd-Chiari syndrome and postnecrotic intrahepatic portal hypertension after shunt surgery","volume":"27","author":"Dang","year":"2012","journal-title":"Chin J Gen Surg"}],"container-title":["Hepatobiliary & Pancreatic Diseases International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387223000395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387223000395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T08:25:59Z","timestamp":1728894359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1499387223000395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1499387223000395"],"URL":"https:\/\/doi.org\/10.1016\/j.hbpd.2023.03.005","relation":{},"ISSN":["1499-3872"],"issn-type":[{"type":"print","value":"1499-3872"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a prognostic scoring system for hepatic vena cava Budd-Chiari syndrome with hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Hepatobiliary & Pancreatic Diseases International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hbpd.2023.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 First Affiliated Hospital, Zhejiang University School of Medicine in China. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}